
Navigating the life science ecosystem
Have you considered what support and opportunities are available to you as a company or entrepreneur working in life sciences? Although there are many opportunities, they can be difficult to find. No longer. There is now a visualisation tool of the life science ecosystem in southern Stockholm.
Flemingsberg Science is responsible for the visualisation, which has been produced within the framework of the Stockholm Life Tech project. The interactive image is based on an overview of everything from innovation support and current actors to research infrastructures and life science companies.
“The aim of the overview and the visualisation is to improve support to all those who need help to make their way through the extensive life science ecosystem. The tools make it easier to find what you’re looking for and to get a better, broader picture of the entire ecosystem,” says Johnny Högberg, CEO Flemingsberg Science.
The visualisation shows the geographical proximity between various actors and entities in Flemingsberg. Testbeds, academic institutions and regional actors are included. There is also a section that shows the area’s specialisations with connections to businesses and support functions.
Click here for the Life Science Ecosystem of Southern Stockholm visualisation.
If you would like to add to the visualisation in any way, please contact: Pernilla Boström at pernilla.bostrom@flemingsbergscience.se.
BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development
As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.
Sally Sow and Turn UP: Winners of the Flemingsberg Science Award IDEA 2024
The music world can be a challenging place, both for organizers trying to reach their audience and for music lovers searching for events that suit their taste. Sally Sow, the winner of the Flemingsberg Science Award IDEA 2024, has developed Turn Up, a platform that simplifies organizing, discovering, and participating in local music events. With a focus on inclusion and accessibility, she aims to create a music scene where everyone feels welcome.
KTH’s Technical Preparatory Year Moves to Flemingsberg – Student Numbers Expected to Double in Autumn 2025
In the autumn of 2025, KTH will relocate its Technical Preparatory Year spots from Södertälje to Flemingsberg, resulting in a significant increase in student numbers at Campus Flemingsberg. By nearly doubling available seats and introducing a new learning center model in collaboration with 3 municipalities, KTH aims to meet the growing demand for technical education in the region.
Drivhuset Stockholm – Where Future Entrepreneurs Take Their First Steps
Imagine a place where young ideas are free to grow, where passion meets ambition, and where the entrepreneurs of tomorrow take their first steps toward greatness. That’s exactly what Drivhuset Stockholm offers – a springboard for the next generation of entrepreneurs. Located on Campus Flemingsberg, we support students every day as they bring their ideas to life and build the skills needed to create real change. Our mission? To provide them with a safe, inspiring environment where they can test and develop their business ideas for real.
OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg
Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on Campus Flemingsberg. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.


